Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 383,097,760
  • Shares Outstanding, K 2,686,520
  • Annual Sales, $ 71,890 M
  • Annual Income, $ 16,540 M
  • 36-Month Beta 0.80
  • Price/Sales 5.27
  • Price/Cash Flow 17.05
  • Price/Book 5.12

Price Performance

See More
Period Period Low Period High Performance
1-Month
136.60 +4.60%
on 11/22/17
143.57 -0.47%
on 12/12/17
+3.13 (+2.24%)
since 11/13/17
3-Month
129.05 +10.72%
on 09/29/17
144.35 -1.01%
on 10/23/17
+10.44 (+7.88%)
since 09/13/17
52-Week
110.76 +29.01%
on 01/25/17
144.35 -1.01%
on 10/23/17
+27.00 (+23.30%)
since 12/13/16

Most Recent Stories

More News
Accelerator Corporation Announces Key Senior Leadership Appointments and Name Change to Accelerator Life Science Partners

Accelerator Corporation, a leading life science investment and management firm, today announced the appointments of Kendall Mohler, Ph.D., to the newly created position of chief development...

JNJ : 142.89 (+0.20%)
JUNO : 47.41 (+3.63%)
Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson are proud to announce the launch of Cancer.com, an online destination providing those impacted by cancer with useful information and tools at the...

JNJ : 142.89 (+0.20%)
Regeneron's sBLA for Eylea Accepted by FDA, Action Date Set

Regeneron (REGN) announced that the FDA has accepted for review the company's supplemental Biologics License Application (sBLA) for Eylea with an action date of Aug 11, 2018.

JNJ : 142.89 (+0.20%)
OPHT : 2.85 (+0.71%)
NVS : 84.66 (+0.24%)
REGN : 386.67 (+1.30%)
JP Morgan Launches Minimum Volatility ETF

JP Morgan rolls out minimum volatility US equity ETF.

USMV : 53.03 (+0.19%)
SPLV : 47.99 (unch)
KO : 45.90 (+1.35%)
HON : 155.80 (+1.34%)
JNJ : 142.89 (+0.20%)
EQR : 65.63 (-1.01%)
JMIN : 25.08 (unch)
MCD : 173.55 (+0.77%)
SYY : 61.62 (-0.36%)
ONEV : 76.30 (unch)
V : 113.31 (-0.13%)
BAX : 64.72 (+0.64%)
PEP : 117.80 (+0.34%)
Markets Right Now: Banks lead US stock indexes mostly higher

The latest on developments in financial markets (All times local):

CMCSA : 38.58 (-2.35%)
JNJ : 142.89 (+0.20%)
JP Morgan Launches Minimum Volatility ETF

JP Morgan rolls out minimum volatility US equity ETF.

USMV : 53.03 (+0.19%)
SPLV : 47.99 (unch)
KO : 45.90 (+1.35%)
HON : 155.80 (+1.34%)
JNJ : 142.89 (+0.20%)
EQR : 65.63 (-1.01%)
JMIN : 25.08 (unch)
MCD : 173.55 (+0.77%)
SYY : 61.62 (-0.36%)
ONEV : 76.30 (unch)
V : 113.31 (-0.13%)
BAX : 64.72 (+0.64%)
PEP : 117.80 (+0.34%)
Motus GI Appoints Gary J. Pruden, Former Worldwide Chairman for Johnson & Johnson Medical Devices Group, to its Board of Directors

Responsible for leading J&J's global medical devices business; 32-year J&J career with senior executive commercial leadership positions across both medical device and pharmaceutical sectors

JNJ : 142.89 (+0.20%)
P. (Laxmin) Laxminarain Appointed to Microbot Medical's Board of Directors

Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced the appointment of P. (Laxmin)...

JNJ : 142.89 (+0.20%)
MBOT : 1.02 (-1.92%)
Lilly Reports Mixed Results from Late-Stage Cyramza Study

Lilly's (LLY) gastric cancer drug, Cyramza, meets primary endpoint of progression free survival in a phase III study in first-line advanced gastric cancer patients. However, it failed to improve overall...

CORT : 17.28 (+0.70%)
JNJ : 142.89 (+0.20%)
LLY : 87.89 (+1.36%)
ACAD : 29.94 (+2.60%)
Incyte (INCY) Reports Phase III Follow-Up Data for Jakafi

Incyte (INCY) announced new 208-week (4-year) follow-up data from the phase III RESPONSE study of Jakafi.

SCMP : 16.50 (+1.23%)
JNJ : 142.89 (+0.20%)
INCY : 98.10 (+2.83%)
NVS : 84.66 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 144.06
1st Resistance Point 143.48
Last Price 142.89
1st Support Level 142.26
2nd Support Level 141.62

See More

52-Week High 144.35
Last Price 142.89
Fibonacci 61.8% 131.52
Fibonacci 50% 127.56
Fibonacci 38.2% 123.59
52-Week Low 110.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.